Skip to main content
Clinical Trials/JPRN-jRCT1032220397
JPRN-jRCT1032220397
Recruiting
未知

A study on cancer screening on HIV-infected patients by blood transfusion

Watanabe Koji0 sites80 target enrollmentOctober 20, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
HIV infection
Sponsor
Watanabe Koji
Enrollment
80
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 20, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Watanabe Koji

Eligibility Criteria

Inclusion Criteria

  • 1\.HIV infected person caused by transfusions of HIV\-tainted blood products
  • 2\.A written informed consent was obtained

Exclusion Criteria

  • 1\.Severe underlying and/or active AIDS disease that need to be treated
  • 2\.Patients who have difficulty to participate in this study due to psychological disease
  • 3\.Patients who are judged to be inappropriate in participation by the attending docter

Outcomes

Primary Outcomes

Not specified

Similar Trials